http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004024897-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1f3f4d137f51855e0e8fa2c5e8455d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_759d53bd75cc185986b2b2e9626b5d91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7451f527e618ddf09b655ce76e99caae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_718804733ee2718d16ab7bb75a3b3c23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_191ff7491be27ce3007e2534d9287e11
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D515-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2003-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f5e5c8fe4c3c4dc2806903028cfd15a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44ffc03a3ca84b729d7e13ba425f9714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3c6421f901c787c000512e2431c6ba0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8785d75ab8adf6949178893a025cb98b
publicationDate 2004-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004024897-A3
titleOfInvention PHENYL-AZA-BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
abstract The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to phenyl-aza-benzimidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents. This invention further relates to small molecules which suppress cytokines and leukocytes.
priorityDate 2002-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6537994-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226527530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21666895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414016310

Total number of triples: 31.